A PROJECT REPORT

ON
HR PRACTICES

AT
WOCKHARDT PVT. LTD

BY
RUBIYABANU HANSROD

UNDER THE GUIDANCE OF

PROF. ANJUM SAYED

SUBMITTED TO
UNIVERSITY OF PUNE

IN PARTIAL FULFILLMENT OF THE REQUIREMENT

FOR THE AWARD OF THE DEGREE OF
MASTER OF BUSINESS ADMINISTRATION (MBA)

THROUGH
AKI, POONA INSTITUTE OF MANAGEMENT SCIENCES
AND ENTREPRENEURSHIP, CAMP,PUNE-16.

Acknowledgement

Human Resource Management is a challenging career that requires not only

theoretical but practical knowledge also and that can be gained through closer
look at HR affairs.

This report is an outcome of project work of two months in WOCKHARDT

LTD.
I am immensely grateful to Dr.R.D.Vaghani (HOD, Dept. of Social Work),
and Mrs. Artiben Oza, for providing me the opportunity to perform the
research study at the WOCKHARDT LTD.
My sincere thanks to MR. Digant Chhaya (Sr. Manager HR) & MR.
Shashikant Panchal (Asst. Manager HR) for the invaluable help and guidance
throughout the training.
I take this opportunity to express my deep sense of gratitude and appreciation to
my project guide Prof. Anjum Sayed (prof. at Poona Institute Of Management
Science & Entrepreneurship, Pune.) for assistance, motivation, and being a
continual source of encouragement for me. Prof. Anjum Sayed gave her timely
guidance, cooperation and encouragement.

Finally,it is my foremost duty to thanks all those person who help me to

complete the project without whom the project would not have been completed.

Place:
Date:
Rubiyabanu Hansrod

Index

Sr.
No.

Particulars

Executive Summary

Introduction

Company & Products Profile

Industry Profile

Objectives and Scope of the Study

Research Methodology

Project Work Undertaken

Data Analysis & Interpretations

Facts & Findings

10

Suggestions

11

Significance & Limitations

12

Conclusion

13

Bibliography

14

Appendix

Page
No.

Chapter-I: Executive summary

Preface

It is said that practice makes a man perfect. In order to achive excellence and
success theoretical knowledge supplement with practical knowledge and
practical work.
Among numerous interesting things concerned with enhancing the
understanding of the management student this practical training for 2 months
plays an important role in development of management student. Moreover in
todays competitive age practical knowledge is more significant the theoretical
knowledge.
The main objective of this training is to develop the student by imparting
knowledge about industrial environment as per business practicals.
I want through a vocational training in Wockhardt and I got nice experience
about industrial environment and business practices.

About the pharmaceutical industries in India

The Indian Pharmaceutical Industry today is in the front rank of Indias sciencebased industries with wide ranging capabilities in the complex field of drug
manufacture and technology. A highly organized sector, the Indian Pharma
Industry is estimated to be worth $ 4.5 billion, growing at about 8 to 9 percent
annually. It ranks very high in the third world, in terms of technology, quality
and range of medicines manufactured. From simple headache pills to
sophisticated antibiotics and complex cardiac compounds, almost every type of
medicine is now made indigenously.
Playing a key role in promoting and sustaining development in the vital field of
medicines, Indian Pharma Industry boasts of quality producers and many units
approved by regulatory authorities in USA and UK. International companies
associated with this sector have stimulated, assisted and spearheaded this
dynamic development in the past 53 years and helped to put India on the

pharmaceutical map of the world. The Indian Pharmaceutical sector is highly

fragmented with more than 20,000 registered units. It has expanded drastically
in the last two decades. The leading 250 pharmaceutical companies control 70%
of the market with market leader holding nearly 7% of the market share. It is an
extremely fragmented market with severe price competition and government
price control.
The pharmaceutical industry in India meets around 70% of the country's
demand for bulk drugs, drug intermediates, pharmaceutical formulations,
chemicals, tablets, capsules, orals and injectibles. There are about 250 large
units and about 8000 Small Scale Units, which form the core of the
pharmaceutical industry in India (including 5 Central Public Sector Units).
These units produce the complete range of pharmaceutical formulations, i.e.,
medicines ready for consumption by patients and about 350 bulk drugs, i.e.,
chemicals having therapeutic value and used for production of pharmaceutical
formulations.
Following the de-licensing of the pharmaceutical industry, industrial licensing
for most of the drugs and pharmaceutical products has been done away with.
Manufacturers are free to produce any drug duly approved by the Drug Control
Authority. Technologically strong and totally self-reliant, the pharmaceutical
industry in India has low costs of production, low R&D costs, innovative
scientific manpower, strength of national laboratories and an increasing balance
of trade. The Pharmaceutical Industry, with its rich scientific talents and
research capabilities, supported by Intellectual Property Protection regime is
well set to take on the international market.
Research & Development is the key to the future of pharmaceutical industry.
The pharmaceutical advances for considerable improvement in life expectancy
and health all over the world are the result of a steadily increasing investment in
research. There is considerable scope for collaborative R & D in India. India can
offer several strengths to the international R & D community. These strengths
relate to availability of excellent scientific talents who can develop
combinatorial chemistry, new synthetic molecules and plant derived candidate
drugs.
The Indian Pharmaceutical companies have been doing extremely well in
developed markets such as U.S & Europe, notable among these being Ranbaxy,
Dr. Reddys Lab, Wockhardt, Cipla, Nicholas Piramal & Lupin. The companies

have their strategies in place to leverage opportunities & appropriate value

existing in formulation bulk drugs, generics, novel drugs delivery systems, new
chemical entities & biotechnology etc.
Many global pharmaceutical majors are looking to outsource manufacturing
from Indian companies, which enjoy much lower costs (both capital and
recurring) than their western counterparts. Many Indian companies have made
their plants cGMP compliant and India is also having the largest number of
USFDA-approved plants outside USA.

Chapter- II: Company Profile

Wockhardt is a global, Pharmaceutical & biotechnology company that has

grown by leveraging two powerful trends impacting the world of
medicine globalization & biotechnology. Wockhardt has build strong
presence in the Indian market with focused efforts on high growth
chronic therapeutic segment. Wockhardt has a 1300-strong field force
covering over 160,000 medical practitioners. The Company's strong focus
covers 50% of the therapeutic segments through six therapy-focussed
marketing divisions. Wockhardt's has a significant presence in pain
management; cough therapy, psychotic drugs, diabetology, vaccines,
nutrition and animal health.
The Company enjoys excellent brand and customer equity, which has
given it leadership positions in its chosen areas of focus.
Wockhardts forte in the Indian market has made it the partner of choice
for reputed international companies. Today, Methycobal, which is
licensed from Eisai, Japan, is the largest selling brand in the segment and
features amongst the Top 50 brands in the country.
Wockhardt offers the requisite resources, distribution & marketing
infrastructure, and brand equity in the Indian market to make it the ideal
partner.
Wockhardt has full-fledged operations in Russia, Ukraine, Kazakhstan,
Brazil, South Africa, Vietnam, Myanmar, Sri Lanka, and the African
countries of Kenya, Ghana, Nigeria and Tanzania.
The Company has entered into joint ventures in Mexico and South Africa,
and has a wholly owned subsidiary in Brazil.
In coming years, these markets will provide avenues for growth as
products go off patent

W - Willingness for safety, Health & Environment

O - Opening for good day for Wockhardian Family

C - Cultivate our knowledge for safety system

K - Keen on our safe work operation system
H - Help as a Fire fighter & first aid
A - Avoid Accident
R - Risk analysis for job area
D - Devotion for each other
T - Train all the employees for safety, health & Environment.

History

The company was established as wockhardt Pvt. Ltd in 1973 by Mr.

Habil Khorakiwala . Starting with marketing formulations, it later looks
up manufacturing. In 1984, it merger two synergistic companies, one
making bulk drugs and the other making dietetic foods. In 1985, it
becomes a deemed public company the banner wockhardt ltd. In 1989,
wockhardt entered the health care segment with wockhardt medical
center in Calcutta.
In 1998, it set up a super specialty hospital & heart Institute. Wockhardt
has maintained its no. one position for brands- Proxy on, Spasm proxy
von, Wok dine, Decdan Tryplomer, Fluoquinolone, and SPARX etc
Until January 2000, Wockhardt was a pharma company that lugged
around a number of risky, capital Intensive, residual business
Wockhardts shareholder, therefore did not quite enjoy the unadulterated
benefits of a stake in the pharmaceutical business unlike their
counterparts in pure pharmaceutical plays.
While Dr.ReddyLaboratories & Ranbaxty were enjoying P/E, multiples
of maximum 50, Wockhardts was hovering way below at 20 around mid
1999. It was then that the company decided to unlock the value in its
pharmaceutical business. With making as Consultant, it decided to
demerge transferring its low-growth, low margin. Life science & hospital

business to wockhardt life science. Ever since, Wockhardt has been on a

strong wicket the company has a sound formulation business that offers
wide therapeutic coverage. Besides, it has a well-planned strategy for
export growth, especially in the generics market.

Wockhardt Group of Company

1. Wockhardt ltd.
2. Carol info service ltd. [Wockhardt life sciences ltd.]
3. Wockhardt hospital ltd.

BOARD OF DIRECTORS

Chairman-Mr.Habil Khorakiwala

Director- Mr. Felipe B Alfonso

Director Mr.Sekhar dutta

Director Dr. Abid Hessian

Director-Dr B L Maheshwari

Director-Mr.Aman Mehta

Director-MR Bharat Mehta

Director Mr. Bharat Patel

Director R.A Shah

VISION

 To be the most admired healthcare group from India.

Corporate Mission

Pursuit of growth with excellence in the field of pharmaceuticals and

Healthcare.

Profitability through
1. Quality of products and services.
2. Increasing investment in R D.
3. Competent scientific and managerial manpower.

QUALITY POLICY

a. Quality is of supreme importance in Wockhardt and

supported by people at all levels, in all functions.
b. Continuous satisfaction of customers is our focus it
means meeting the requirements of internal and
external customers with speed right the first time,
every time.
c. Quality is built into process we must ensure
consistency through Continuous follow up and
adherence to established Company policies and
procedures.

d. Quality is measurable and continuous feedback and

improvement is a part of our Quality improvement
process.
e. Continuous communication with Wockhardians and
their involvement is critical for Quality.

Safety, Health and Environment Policy

To strictly comply with all relevant laws, regulations, statutory provisions and
codes of practices.
To provide and maintain facilities, equipment, operation process and working
conditions which are safe for employees and contractors in our quest towards
achieving our goal of becoming a zero accident, illness and injury company.
To continuously assess risks and hazards so as to evolve, establish and upgrade
hazard control measures, emergency preparedness and risk mitigations.
To ensure safe handling, storage, use and disposal of all substances and
materials which are classified as hazardous to health and environment.
To contribute towards sustainable development through compliance with laid
down environmental regulations and by reducing pollution and waste,
conserving and promoting recycling of material wherever possible.
To create awareness in employees by provide appropriate training , motivation
& information so as to create an individual sense of duty, responsibility &
participation and an institutionalized culture of continuous improvement in
safety, health and environmental matters.
To institute and implement a system of regular safety, health and environmental
audits in order to ensure compliance with laid down polices, laws and statutory
regulations and correct any deficiencies identified in a timely manner.
To conduct constant research and development and assimilate emerging
technologies in plant, system and process towards enhancement of safety, health
and environmental matters.

 PRODUCT PROFILE

Wcokhardt s has significant presence in management

cough therapy, psychotic drugs, and diabetology,
vaccines , nutrition and animal health.

The company enjoys excellent brand and customer

equity, which has given it Leadership positions in its
chosen areas of focus.

Diabatology Wosulin (Recombinant Insulin),

Mopaday (Oral Antidiabetic), Glimaday (Oral
Antidibetic)
Nephrology Wepox (Recombinant Erythropoietin0
Neuro Psychiatry Libotryp Tryptomer
Cough Therapy Zedex Bro-ZEDEX Viscodyne

WOCKHARDT, ANKLESHWAR

(Regulatory status)
Various Approvals
US-FDA (API Mfg)

FDA India (API Mfg)

WHO (API Mfg)
ISO 9001: 2000 (API Mfg) Ankleshwar.
IDP China (API Mfg) Ankleshwar.
CEP Certifications from EDQM for 6 Drugs
ANDA approvals from US-FDA for 9 Drug and many
more.

WOCKHARDT, (ANKLESHWAR)

Manufacturing Plants:

It has about six manufacturing plants of which 34 is USFDA means (Food, Drug, & Advances)
approved like the ones in Daman & Ankleshwar.
Further, Wockhardt in setting up a biotech park
in Aurangabad exclusively for the production of
biotech products.

-API manufacturing facility

-About 320 Kms. North of Mumbai
-Total Plot Area (approx.): 75000 sq.m.
-Total strength (about): 320 persons.

 Corporate Value

-Integrity, loyalty, commitment.

-High quality product and services.
-Objectivity and fairness.
-Consistent growth.
-Style is participative.
-Positive corporate image.
-Creativity and Aesthetic sense.
-Trust.
-Secular approach.
-Systematic yet simple.
-Development of people.
-Freedom of Expression.

Competitors

Ranbaxy Laboratory
Dabur India Ltd.
Abbott India
More pen Laboratory
Korpan

 Sun Pharmaceuticals Industry Ltd.

Micholas piramal India Ltd.
Cadila Pharmaceutical Ltd.
Glaxo smitkline Pharmaceutical Ltd.
Glenmark Pharma Ltd.

financial /statistical data (sales, turnover, market share etc)

1. Sales: - CAGR of 22% for last 10 Years

2. Profitability: - CAGR of 30% for last 10 Years
3. 400 Scientists in R&G
4. Market Capitalization Rs. 36bn ($ 800 mn)
5. R & D Spend CAGR of 63% Over 10 Years
6. 5000 employees world wide
Business structure Geographical distribution

Europe

- 41%

India

- 37%

Row

- 11%

U.S

- 11%

Sales for first year 2005-2006 14.1 billion.

organization chart

Sr Manager

Asst. Manager

Executive

OFFICER

OFFICER

. General Manager

- Recruitment of personnel.
- Planning and providing training as per identification needs.
- Co-operation relating training matters and establishing training
effectiveness.
- Liaisoning and co-operation with Govt. bodies, local association and
compliance to statutory requirement keeping tasks of updating of acts
codes etc. in the respective functions.

2. Executive

- To assist in recruitment and selection procedure.

- To maintain personnel record.

- Return under the various labour laws.
- To assist/attend the legal matters.
- To assist for preparation of various reports.
- To arrange promotional tests etc. as per the promotional policy.

3.Welfare Officer

- All functions of time office.

- Overall house keeping.
- Liasioning with factory inspector.

Departments

Marketing department

Marketing department provides information about the sales forecasting

done on the basic of the market situation.
It also forecasts sales based on previous years sale.

It forecasts for local market and international market.

It forecasts about the traveling expense that the companys will incur.

Production department

Production department forecasts about raw material requirement.

It decides manufactures from whom to buy a raw material.

It provides information about the expected price (avg. rate annually)

Maintenance department
It provides information about repairs and maintenance required.

Personnel department
It provides information about budget salary and personnel requirements.

R & D department
It provides information about if any new product development takes place or if
new chemical is required for the laboratory or any breakdown

Finance department

It also incurs expenditure like software system, stationary, traveling

expenses etc.
For budgetary control company coordination between all departments is
necessary.
It is necessary to plan for the company as how much it would the bank
facility for budgetary control.

It decides source and types funds for financing capital expenditure.

It also plans for saving and cost reduction.

It also encourages controlling of individual expenses.

It evaluates actual and standard expense and income and taxes some
decision actions.

Budget manual
It deals with calculating individual expenses and has control on each
department and employee working in the company.
Budget period
Budget period generally it is yearly planning from January to December, which
is their financial year.

Principle budget factor:

Marketing

Sales planning

Production planning

Purchase planning

Labour cost planning

Budget centre:
Budget center is either department wise or product wise. Here in Wockhardt
plant is taken as department and hence plants wise.
BUSINESS FUNCTIONS

1. Marketing

2. Manufacturing
3. R&D
4. Services

1. MARKETING
Domestic pharmaceutical
Global subsidiaries
Animal health
Export domestic API

2. SUPPORTED BY MANUFACTURING
Bulk drugs bhandup, ankleshwar
Recombinant bio pharmaceuticals
Milk products: chandighar
Formulations: chikalthana, Daman waluj

3. SERVICED BY
Global scientific & regulatory affairs
Medical
Business development
Projects
Supply chain \ Finance +IT
HR / legal
Corporate relation

MIP
4Driven by R&D
Biotechnology
ANDA
Chemical & clinical Research
Formulations Development

History & milestones of our Ank API facility:

1984: commissioned 1st bulk drug plant (we call as bd-1 plant)
1989: Dextropropoxyphene HCL got National award on its inception.
1993: Commissioned 2nd bulk drug plant inaugurated by the former chief
minister
of Gujarat state, late. Chimanbhai. (BD-2 plant)
1999: commissioned cephalosporin plant 100% EOU11 (we call non
sterile plant as bd-5, 6&sterile as bd-7 plant)
2006-commissioned multi purpose plant 100%EOU11
2008- commissioned multi purpose plant - 2 100%EOU11

Chapter-III: Objectives of the study

TITLE OF THE STUDY:

HR PRACTICES at Wockhardt Pvt. Ltd

JUSTIFICATION OF THE TITLE:

This particular topic is chosen because,

To Understand the top 5 HR Practices conducted at Wockhardt which
make it one of the successful Indian Pharmaceutical Industry.
there is a study of top 5 HR Practices provided with the
assistance of departments, on how good HR practices
can enhance service productivity and quality. The
Practices are grouped under the following categories
Articulation of Vision, Mission and Values
Manpower Planning
Performance Management
Training and Development
Service Quality Enhancement

OBJECTIVES OF THE STUDY:

Study to manage employees with more progressive HR

practices can expect to see higher operational
performance as a result.
To understand the process of detail manpower requirement and means
of meeting that requirement in order to carry out the integrated plan of
the Organization.
To know the work performance of employee on the present job
relation to the expected levels of performance, both qualitative &
quantitative.
To understand the employee growth and development through
training, self and management development programmes.
To ensure organizational effectiveness through correcting employee
for standard and improved performance, and suggesting the change
for quality of services.

Chapter-IV: Research Methodology

The term research refers to the systematic method consisting of enunciating the
problem, formulating a hypothesis, collecting the facts of data, analyzing the
facts and reaching certain conclusions either in the form of solution towards the
concerned problem or in certain generalization for some theoretical formulation.
The purpose of research is to discover increase to questions through the
application of scientific procedures. The main of research is to unravel the truth
which is hidden and which has not been discovered yet.

RESEARCH DESIGN:

There are two types of research design i.e. exploratory & descriptive research
design. I have chosen descriptive research design; survey was conducted to
collect the relevant data.

DATA COLLECTION METHOD:

There are two type sources of data i.e. primary & secondary data. I have chosen
primary data through observations i.e. survey method.

Primary data would be helpful for me to get information through interacting

with the employees.
Primary data is being collected during the course of asking questions by
performing survey. Primary data is obtained either through respondent; either

through questionnaire or through personal interviews. Some of the clients will

be interviewed personally and questionnaire will be filled by them.
(Primary data can be collected through direct interview, questionnaires
observations etc.)

Sources of primary data:

For this project Primary data was collected through the following methods by
the researcher.
Questionnaire method
Interview method
Questionnaire method was most commonly used to collect the primary data.
Besides that interviews were taken to acquire first hand information.
Secondary data
Secondary data are the data already available in form of print material, websites
journals etc.

Sources of secondary data:

Journals and magazines.
Internet (related websites)
Text books
Secondary data from internet and various reports will be collected and an
overview of company environment will be studied.

Sample size

The larger the sample, the more accurate the results would be but practically it
is not feasible to survey the entire target population or even a substantial portion
of it.
Sample Size is 200 respondents.

Sampling method

The sampling method used is non-probability sampling in which convenience

and purposive sampling method has been used.
Sampling procedure: Simple Random Sampling procedure was followed.
Sampling Method: Data was collected by survey.

Data collection or evidence gathering

Population of the study:

The employees are divided in to management staff i.e. Executive, Sr.executive,
Officer, and Sr.officer.
Each respondent will be interviewed for the duration of at least 10-15 minutes.
During the interview a self-administered written Questionnaire was asked to the
respondents. Keeping this in mind the following points will be taken care of
while asking questions:
Asking the questions exactly as they are worded in the questionnaire.
Reading each question very slowly.
Asking the question in the order in which they are presented in questionnaire.
Asking every question specified in questionnaire.
Repeating and clarifying the questions that are misunderstood or misinterpreted.

Processing and analyzing the data

After gathering the data from various sources, the researcher has to analyze it to
sort out relevant information. The unwieldy data should necessarily by condense
into a few manageable groups and tables for further analysis. In this project,
after collecting the data from client companies, all data will be properly
analyzed. Various table and graph were prepared. Multiple regressions were also
used during analysis. Comments and suggestions from respondents will be
noted down separately.

Preparation of Research Report and presentation

As the last step of research the collected information/data and findings will be
submitted to the company and to the project guides along with my opinions and
observations which I experienced throughout doing the project.

SIGNIFICANCE & LIMITATIONS

Significance of the Study:
The project directly deals with interaction of different kinds of people. So
this project helps me to understand the corporate communication system.
This study is helpful in finding out the effects on consumers value and
satisfaction.
This study provides an insight to the Company that what kind of strategy
must be adopted in order to increase the sales and satisfaction of the consumers.

Limitations of the study:

Though this study was taken up with sincere effort to accomplish the objectives,
there were certain factors that held back the satisfactory completion of the same.
These factors include:
The study being taken in the peak season of May, June might not have
produced accurate data.
Some retailers shown non-cooperative behavior at the time of data collection
of this study.
The research was dependent upon information provided by the respondents
(retailers). It may be biased or insufficient.
Finding and Analysis was for the specific area (route) only.

 Review of literature

Chapter-V: Project work undertaken (HR PRACTICES)

There is a study of top 5 HR Practices provided with the assistance of

departments, on how good HR practices can enhance service
productivity and quality. The Practices are grouped under the
following categories:
Articulation of Vision, Mission and Values.
Manpower Planning.
Performance Management.
Training and Development.
Service Quality Enhancement.

1. Articulation of Vision, Mission and Values.

Human Resource Management (HRM) is a planned approach to managing

people effectively for performance. It aims to establish a more open, flexible
and caring management style so that staff will be motivated, developed and
managed in a way that they can give of their best to support departments
missions. Good HR practices are instrumental in helping achieve departmental

objectives and enhance productivity. For the purpose of sharing experience and
providing reference in launching HRM initiatives.